CRISPR-based testing feasible for SARS-CoV-2 screening
CPR quality impacts survival in in-hospital cardiac arrest
17 February 2021Research finds new link between personality and risk of death
17 February 2021CRISPR-based testing feasible for SARS-CoV-2 screening
(HealthDay)—CRISPR-based assays appear to be reliable for surveillance testing and detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks in higher education settings, according to a study published online Feb. 11 in JAMA Network Open.
